MIRXES-B (02629) has announced that the existing lock-up commitments concerning company shares held by its co-founders and cornerstone investors are set to expire on February 23, 2026. Following the expiration of the current lock-up period, the co-founders—Dr. Zhu Xingfen (holding 32.4194 million shares), Dr. Zhou Lihan (controlling 18.6606 million shares via SLW Gene Limited), and Dr. Zou Ruiyang (controlling 17.8606 million shares via Accurate Gene Limited)—along with cornerstone investor Beijing Xun Rui Enterprise Management Partnership (holding 16.6492 million shares), have voluntarily provided commitments to the company regarding their respective equity stakes. These voluntary pledges reflect the co-founders' and cornerstone investor’s firm confidence in the company’s long-term development prospects, business foundation, and strategic direction, demonstrating their intention to hold the company’s shares over the long term and support sustainable growth and value creation.

Under the voluntary commitments, during the 12-month period starting February 23, 2026: (i) each co-founder has pledged not to sell any of their relevant shares; and (ii) the cornerstone investor has committed to retain no less than 80% of its relevant shares. Additionally, the company believes that these voluntary pledges also reflect the co-founders' and cornerstone investor’s recognition of positive developments in the company’s business, including but not limited to recently announced strategic initiatives related to new merger and acquisition projects, R&D progress in its pipeline products (including multi-cancer early detection solutions), and expansion into emerging markets. The company will continue to build on this foundation to achieve its long-term development goals, aligning with the interests of its shareholders.